. Absorption spectra of (a) MTX (30 M) and (b) FA (30 M) at several pH conditions 
Time Resolved Fluorescence Studies Fluorescence decay measurement
In order to interpret the dynamics of the drug molecule within the heterogeneous environment, the time-resolved fluorescence decay of MTX and FA has been recorded in the presence of HSA.
Representative decay profiles are highlighted in Figure S5 and fitted data are tabulated in 
Fluorescence anisotropy decay measurement
The time resolved anisotropy measurements provide information about the alteration of microenvironment around the drug molecule. 1 The estimated rotational correlation time ( r ) also furnishes the extent of rigidity of any microheterogeneous media. 1 Therefore, the time-resolved anisotropy measurement provides additional information about the bound and unbound forms of the drug in protein drug complexation. The typical anisotropy decay profiles of the drug in the aqueous buffer as well as in the protein environment are highlighted in Figure S6 and the fitted data are summarized in Table S2 . In aqueous buffer medium both of the drug exhibit single rotational decay time (0.20 ns for MTX and 0.11
for FA), indicate that unbound (free) form of the drugs is experiencing a homogeneous medium. In 
S10

Docking Analysis and Possible Mode of Interaction
We investigate the possible locations of these two drugs molecule with the help of docking analysis. The geometry of MTX and FA has been first optimized by PM3 prescription using Gaussian 03 and the resultant geometries have been read in AutoDock 4.2 software in compatible file format, from which the required file is generated in AutoDock 4.2. 3 The grid size is set to 60, 60, and 60 along the x-, y-, and zaxis with 0.5 Å grid spacing; i.e., to recognize the drugs within the binding pockets of HSA. The lowest binding energy conformer has been searched out of 80 different conformers for each docking simulation, and the resultant one is used for further analysis. In this case, blind docking of MTX and FA have been performed into the 3D Crystal structure of HSA and it has been found that MTX majorly binds in the two sites, whereas preferable site for FA is one, as the experimental result suggest. To get the competitive binding account, we performed docking over one pre-exists drug molecule. Now combining the result of the experimental findings and docking simulations have been described, making the following points. and it is the subdomain IIA and IIIA (see the Figure S11 ). Minimum energy docked pose of FA is displayed in Figure S12 , and adjacent protein residues (within 6.0 Å) surrounding the protein-bound drug molecule (Tyr150, Lys195, Lys199, Trp214, Arg218, Leu219, His242, Arg257, Ala291, Glu292, Asn295, Lys444, Pro447, Lys448) reveal that FA prefers to bind in subdomain IIA. Figure S13 ). As this site possess less charged amino acid residue, the - interactions are the presumably major binding factor here.
The change in SASA value also displayed the significant involvement of side chain amino acid reduces shown in Table S3 . This table suggests that SASA value of positively charged and polar uncharged side chain residues is significantly altered for docking of the molecule in first binding site. At the second binding site, the SASA value of hydrophobic residues is predominantly changed, although the noticeable change in SASA value of Arg209 and Lys351 residues also implies some involvement of the positive charge in this pocket. Wavenumber (cm -1 ) 
